샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777547

세계의 시퀀싱 소모품 시장

Sequencing Consumables
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 381 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 시퀀싱 소모품 시장은 2030년까지 266억 달러에 도달

2024년에 82억 달러로 추정되는 시퀀싱 소모품 세계 시장은 2024-2030년간 CAGR 21.6%로 성장하여 2030년에는 266억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 키트는 CAGR 23.6%를 나타내고, 분석 기간 종료시에는 183억 달러에 이를 것으로 예측됩니다. 시약 부문의 성장률은 분석 기간중 CAGR 17.3%로 추정됩니다.

미국 시장은 22억 달러로 추정, 중국은 CAGR29.2%로 성장 예측

미국의 시퀀싱 소모품 시장은 2024년에 22억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 64억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 29.2%로 추정됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 17.0%와 19.4%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 18.1%를 나타낼 전망입니다.

세계의 시퀀싱 소모품 시장 - 주요 동향과 촉진요인 정리

차세대 시퀀싱이 소모품 수요의 전례 없는 증가를 촉진할 수 있을까?

연구, 임상, 산업 분야에서 차세대 염기서열분석(NGS) 플랫폼이 널리 채택되면서 전 세계적으로 염기서열분석 소모품에 대한 수요가 크게 확대되고 있습니다. 시퀀싱 소모품에는 시퀀싱에 필요한 시약, 시약, 시료, 키트, 효소 및 기타 단일 사용 품목이 포함되며, 유전체 밸류체인의 중요한 백본을 형성합니다. 시퀀싱 기술의 스루풋, 정확도, 접근성이 향상됨에 따라 소모품의 사용량은 기하급수적으로 증가합니다. 조사에서는 집단 유전학, 종양학, 후성유전학, 후성유전학, 마이크로바이옴 분석 등 대규모 유전체 연구가 확대되면서 고충실도 시퀀싱 키트 및 시약이 대량으로 소비되고 있습니다. 또한, 개인 맞춤형 의료가 점점 더 중요해지면서 임상 검사들이 견인력을 얻고 있으며, 암, 희귀질환, 감염성 질환 프로파일링, 약리유전체학 등의 진단 검사들이 증가하고 있습니다. 이러한 이용 사례는 각각 품질, 감도, 처리 속도에 대한 고유한 요구 사항을 가지고 있으며, 범용 소모품과 용도별 소모품이 모두 급증하고 있습니다. 또한, 시퀀싱 장비의 기술 혁신 속도가 빠르기 때문에 호환 가능한 소모품도 끊임없이 반복과 업그레이드를 반복하여 복잡성이 증가하여 수요가 다시 증가하고 있습니다.

자동화와 워크플로우 최적화가 제품 개발을 어떻게 재정의하고 있는가?

실험실 자동화와 통합 시퀀싱 및 검사 흐름의 발전은 소모품을 둘러싼 기대치를 크게 변화시켰습니다. 바이오의약품 R&D, 학술 연구실, 상업적 서비스 제공업체 등 모든 하이 스루풋 환경에서 속도, 일관성, 자동화 시스템과의 호환성을 위해 최적화된 소모품이 점점 더 선호되고 있습니다. 이러한 변화는 특히 미리 채워진 시약 카트리지, 즉시 사용 가능한 시료 준비 키트, 간소화된 라이브러리 준비 시약의 설계에서 나타나며, 인위적인 실수와 작업 시간을 줄일 수 있습니다. 또한 포장 형태, 시약의 안정성, 온도 내성 등에서도 혁신적이어서 임상 실험실, 이동형 검사실, 소규모 연구시설 등 분산형 검사 환경의 운영 요구를 충족시킬 수 있습니다. 또한, 단일 세포 검사, 공간 전사체학, 멀티오믹스 접근법은 초고감도 및 특이성을 갖춘 특수 소모품 포멧의 도래를 예고하고 있습니다. 이러한 기술 혁신은 정밀 종양학, 신경유전학, 병원체 모니터링 등 새로운 이용 사례를 지원하는 데 매우 중요합니다. 엔드투엔드 워크플로우 솔루션으로의 전환으로 인해 장비 제조업체들은 자체 소모품에 대한 의존도를 낮추고, 최적의 성능을 보장하면서 사용자를 특정 에코시스템에 묶어두기 위해 노력하고 있습니다.

세계 격차와 공급망 역학이 시장 모멘텀에 영향을 미칠까?

연구 자금, 의료 인프라, 규제 프레임워크의 지리적 격차는 시퀀싱 소모품의 채택에 있어 불균등한 패턴을 만들어내고 있습니다. 북미는 생물 의학 연구에 대한 활발한 투자, 유전자 검사에 대한 유리한 상환, 유전체학 기업 및 시퀀싱 기술 리더의 집적에 힘입어 계속해서 선두를 달리고 있습니다. 유럽은 광범위한 정밀의료에 대한 노력과 민관 파트너십이 보급을 촉진하면서 근소한 차이로 뒤를 잇고 있습니다. 한편, 아시아태평양은 중국, 인도, 일본의 유전체 프로그램 확대와 진단 인프라 및 현지 제조 능력 향상에 힘입어 고성장 지역으로 부상하고 있습니다. 그러나 지정학적 긴장, 팬데믹으로 인한 혼란, 물류 제한으로 인한 공급망 제약으로 인해 중요한 소모품의 적시 공급을 방해하는 경우도 있습니다. 시장은 제조의 지역화, 재고 탄력성 강화, 공급업체-네트워크의 다양화 등의 노력으로 대응해 왔습니다. 소모품에 포함된 일회용 플라스틱과 유해 화학 폐기물을 둘러싼 환경 문제에 대한 우려도 업계 관계자들에게 친환경 대체품 및 지속 가능한 생산 모델을 모색하도록 촉구하고 있습니다. 비용에 민감한 시장을 가진 지역에서는 성능과 접근성의 균형을 갖춘 합리적인 가격의 모듈식 소모품 옵션에 대한 수요가 증가하고 있으며, 이는 단계별 제품 라인과 지역별 가격 전략의 길을 열어주고 있습니다.

시퀀싱 소모품 시장의 급성장 원동력은 무엇인가?

시닝 소모품 시장의 성장은 기술 발전, 최종 사용자 확대, 소비 패턴의 변화와 직결되는 몇 가지 요인에 의해 주도되고 있습니다. 첫째, 전 세계적으로 고투과율 검사기, 특히 벤치탑 및 임상급 플랫폼의 보급으로 인해 핵심 실험실과 위성 실험실 모두에서 일상적인 소모품의 사용이 증가하고 있습니다. 둘째, 롱리드, 나노포어, 단일 분자 시퀀싱과 같은 새로운 시퀀싱 기술의 출현으로 이러한 플랫폼에 맞는 새로운 카테고리의 특수 시약 및 화학 키트에 대한 수요가 발생하고 있습니다. 셋째, 농업, 식품안전, 법의학, 수의학 등 시퀀싱 용도의 다양화로 인해 시료 전처리, 증폭, 시퀀싱용 소모품에 크게 의존하는 최종 용도가 새롭게 생겨나고 있습니다. 넷째, 특히 감염성 질환 검출 및 신생아 스크리닝에서 분산형 검사 모델과 현장 검사(Point-of-Care)의 확산이 진행됨에 따라 휴대가 가능하고 안정적이며 사용하기 쉬운 소모품 폼매트에 대한 니즈가 증가하고 있습니다. 다섯째, 최종 사용자는 더 높은 스루풋과 재현성을 원하고 있으며, 통합된 실험실 생태계와 호환되는 검증된 자동화 지원 소모품을 선호하고 있습니다. 마지막으로, 시큐리티 시스템 업체들 간의 경쟁이 치열해지면서 소모품은 수익성이 높은 지속적인 수익원으로서 독자적인 제품 생태계, 구독 모델, 부가가치 서비스 번들링에 대한 공격적인 전략이 요구되고 있습니다. 이러한 요인들이 복합적으로 작용하여 시퀀싱 소모품은 더 이상 보조적인 요소가 아니라 더 넓은 유전체학 시장에서 핵심적인 수익 및 혁신 촉진 요소로 자리 잡고 있습니다.

부문

제품(키트, 시약, 액세서리), 용도(암 진단, 감염증 진단, 생식 의료 진단, 약물유전체학, 아그리유전체학, 기타), 최종 용도(제약 기업 및 바이오테크놀러지 기업, 병원·연구소, 학술연구기관, 기타)

조사 대상 기업 예

  • Agilent Technologies, Inc.
  • Analytik Jena AG
  • Beckman Coulter, Inc.
  • BGI Genomics
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eurofins Genomics
  • F. Hoffmann-La Roche Ltd.
  • GATC Biotech(Eurofins Genomics)
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Invitrogen(Thermo Fisher Scientific)
  • LGC Biosearch Technologies
  • Lucigen Corporation
  • Macrogen Inc.
  • MGI Tech Co., Ltd.
  • Micronit
  • Millipore Sigma
  • New England Biolabs, Inc.
  • Nugen Technologies, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Swift Biosciences, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Zymo Research Corporation

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH

Global Sequencing Consumables Market to Reach US$26.6 Billion by 2030

The global market for Sequencing Consumables estimated at US$8.2 Billion in the year 2024, is expected to reach US$26.6 Billion by 2030, growing at a CAGR of 21.6% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 23.6% CAGR and reach US$18.3 Billion by the end of the analysis period. Growth in the Reagents segment is estimated at 17.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 29.2% CAGR

The Sequencing Consumables market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 29.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.0% and 19.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 18.1% CAGR.

Global Sequencing Consumables Market - Key Trends & Drivers Summarized

Is Next-Generation Sequencing Fueling an Unprecedented Rise in Consumables Demand?

The widespread adoption of next-generation sequencing (NGS) platforms across research, clinical, and industrial domains has significantly amplified the demand for sequencing consumables worldwide. Sequencing consumables - which include reagents, flow cells, kits, enzymes, and other single-use items necessary for sequencing workflows - form a critical backbone of the genomic value chain. As the throughput, accuracy, and accessibility of sequencing technologies improve, consumable utilization scales exponentially, driven by the sheer volume of sequencing tests being performed across a growing array of applications. In research, expanding large-scale genomic studies such as population genetics, oncology, epigenetics, and microbiome analyses are consuming vast quantities of high-fidelity sequencing kits and reagents. Additionally, clinical sequencing is gaining traction due to the increasing emphasis on personalized medicine, leading to a rise in diagnostic sequencing for cancer, rare diseases, infectious disease profiling, and pharmacogenomics - all requiring specialized, clinical-grade consumables. Each of these use cases brings unique requirements for quality, sensitivity, and processing speed, prompting a surge in both general-purpose and application-specific consumables. Furthermore, the rapid pace of innovation in sequencing instrumentation is leading to constant iterations and upgrades in compatible consumables, adding layers of complexity and fueling recurrent demand.

How Are Automation and Workflow Optimization Redefining Product Development?

Advancements in laboratory automation and integrated sequencing workflows have significantly altered the expectations surrounding consumable products. In high-throughput settings, whether in biopharma R&D, academic labs, or commercial sequencing service providers, there is an increasing preference for consumables that are optimized for speed, consistency, and compatibility with automated systems. This shift is particularly visible in the design of pre-filled reagent cartridges, ready-to-use sample prep kits, and streamlined library preparation reagents that reduce human error and hands-on time. Manufacturers are also innovating in packaging formats, reagent stability, and temperature tolerance, catering to the operational needs of decentralized sequencing environments such as clinical labs, mobile testing units, and smaller research facilities. Moreover, single-cell sequencing, spatial transcriptomics, and multi-omics approaches are ushering in specialized consumable formats with ultra-high sensitivity and specificity. These innovations are critical in supporting emerging use cases like precision oncology, neurogenetics, and pathogen surveillance. The move toward end-to-end workflow solutions has made sequencing instrument manufacturers double down on proprietary consumables, locking users into specific ecosystems while ensuring optimal performance - a trend that, although controversial, is proving lucrative and strategically advantageous.

Can Global Disparities and Supply Chain Dynamics Influence Market Momentum?

Geographic disparities in research funding, healthcare infrastructure, and regulatory frameworks have created uneven patterns in sequencing consumables adoption. North America continues to lead due to robust investments in biomedical research, favorable reimbursement for genetic testing, and the concentration of genomics firms and sequencing technology leaders. Europe follows closely with extensive precision medicine initiatives and public-private partnerships driving uptake. Meanwhile, the Asia-Pacific region is emerging as a high-growth zone, fueled by expanding genomic programs in China, India, and Japan, alongside improvements in diagnostic infrastructure and local manufacturing capabilities. However, supply chain constraints - exacerbated by geopolitical tensions, pandemic-related disruptions, and logistics limitations - have occasionally hindered the timely availability of critical consumables. The market has responded with efforts to regionalize manufacturing, enhance inventory resilience, and diversify supplier networks. Environmental concerns surrounding single-use plastics and hazardous chemical waste in consumables are also prompting industry players to explore greener alternatives and sustainable production models. In regions with cost-sensitive markets, demand is growing for affordable, modular consumable options that balance performance with accessibility, paving the way for tiered product lines and localized pricing strategies.

What’s Driving the Surging Momentum in the Sequencing Consumables Market?

The growth in the sequencing consumables market is driven by several factors directly tied to technology evolution, end-user expansion, and changing consumption patterns. First, the increasing global adoption of high-throughput sequencers, particularly benchtop and clinical-grade platforms, is pushing up routine consumable usage in both core and satellite labs. Second, the emergence of novel sequencing techniques - including long-read, nanopore, and single-molecule sequencing - is generating demand for new categories of specialized reagents and chemistry kits tailored to these platforms. Third, the diversification of sequencing applications across agriculture, food safety, forensics, and veterinary sciences is creating new end-use verticals that rely heavily on consumables for sample prep, amplification, and sequencing. Fourth, the growing prevalence of decentralized testing models and point-of-care sequencing, particularly in infectious disease detection and newborn screening, is increasing the need for portable, stable, and user-friendly consumable formats. Fifth, end-users are demanding higher throughput and reproducibility, leading to increased preference for pre-validated, automated-ready consumables compatible with integrated lab ecosystems. Finally, competitive dynamics among sequencing system manufacturers have intensified, with consumables serving as a high-margin, recurring revenue stream - prompting aggressive strategies around proprietary product ecosystems, subscription models, and value-added service bundles. Together, these factors are cementing sequencing consumables not just as supporting elements but as central revenue and innovation drivers within the broader genomics market landscape.

SCOPE OF STUDY:

The report analyzes the Sequencing Consumables market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Kits, Reagents, Accessories); Application (Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics, Others); End-Use (Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Agilent Technologies, Inc.
  • Analytik Jena AG
  • Beckman Coulter, Inc.
  • BGI Genomics
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eurofins Genomics
  • F. Hoffmann-La Roche Ltd.
  • GATC Biotech (Eurofins Genomics)
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Invitrogen (Thermo Fisher Scientific)
  • LGC Biosearch Technologies
  • Lucigen Corporation
  • Macrogen Inc.
  • MGI Tech Co., Ltd.
  • Micronit
  • Millipore Sigma
  • New England Biolabs, Inc.
  • Nugen Technologies, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Swift Biosciences, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Zymo Research Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Sequencing Consumables - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Genomic Research and Personalized Medicine Throws the Spotlight on High-Throughput Sequencing Consumables
    • Rapid Expansion of Clinical Diagnostics Strengthens the Business Case for Scalable Sequencing Reagents and Kits
    • Growth of Cancer Genomics and Liquid Biopsy Applications Propels Demand for High-Fidelity Sample Prep Consumables
    • Here's How the Rise of Precision Medicine Is Driving Adoption of Next-Generation Sequencing (NGS) Workflows
    • Technological Innovations in Library Preparation and Target Enrichment Enhance Accuracy and Workflow Efficiency
    • Increasing Utilization of Sequencing in Infectious Disease Surveillance Expands the Addressable Consumables Market
    • Emergence of Portable and Point-of-Care Sequencers Spurs Growth in On-Demand Consumable Solutions
    • Integration of Automation and Robotics in Genomics Labs Drives Standardization and Consumable Throughput
    • Here's the Story Behind Biopharma's Rising Demand for Sequencing in Drug Discovery and Companion Diagnostics
    • Growth in Agricultural Genomics, Microbiome Research, and Environmental DNA Analysis Opens New Market Segments
    • Shift Toward Multi-Omics and Single-Cell Sequencing Drives Innovation in Consumable Chemistry and Format Design
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sequencing Consumables Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sequencing Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sequencing Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Sequencing Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Reproductive Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Reproductive Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Reproductive Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Pharmacogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Pharmacogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Pharmacogenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Agrigenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Sequencing Consumables by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Sequencing Consumables by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Sequencing Consumables by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Spain 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Russia 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Sequencing Consumables by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Sequencing Consumables by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Australia 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 176: India Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: India 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: South Korea 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Sequencing Consumables by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Sequencing Consumables by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Latin America 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Argentina 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Brazil 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Mexico 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Sequencing Consumables by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Sequencing Consumables by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Middle East 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Iran 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Israel 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: UAE 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Africa 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제